Galectin-3 deficiency reduces the severity of experimental autoimmune encephalomyelitis.
about
Dendritic cell interactions with Histoplasma and ParacoccidioidesCharacterization of inflammatory gene expression and galectin-3 function after spinal cord injury in mice.The roles of Galectin-3 in autoimmunity and tumor progressionGalectins: regulators of acute and chronic inflammationInflamed In Vitro Retina: Cytotoxic Neuroinflammation and Galectin-3 ExpressionLipocalin-2 protein deficiency ameliorates experimental autoimmune encephalomyelitis: the pathogenic role of lipocalin-2 in the central nervous system and peripheral lymphoid tissues.Galectin-8 as an immunosuppressor in experimental autoimmune encephalomyelitis and a target of human early prognostic antibodies in multiple sclerosis.Allergen-induced airway remodeling is impaired in galectin-3-deficient miceMammalian target of rapamycin inhibition and alloantigen-specific regulatory T cells synergize to promote long-term graft survival in immunocompetent recipientsGalectin-3 is a candidate biomarker for amyotrophic lateral sclerosis: discovery by a proteomics approach.Deletion of IL-33R (ST2) abrogates resistance to EAE in BALB/C mice by enhancing polarization of APC to inflammatory phenotypeThe role of Galectin-3 in α-synuclein-induced microglial activation.T-cell growth, cell surface organization, and the galectin-glycoprotein lattice.Galectin-3 drives oligodendrocyte differentiation to control myelin integrity and function.Galectin-8 Ameliorates Murine Autoimmune Ocular Pathology and Promotes a Regulatory T Cell Response.Serum galectin-3 levels in children with chronic hepatitis B infection and inactive hepatitis B carriersSelf-assembled glycopeptide nanofibers as modulators of galectin-1 bioactivity.Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration.When galectins recognize glycans: from biochemistry to physiology and back againDeletion of galectin-3 exacerbates microglial activation and accelerates disease progression and demise in a SOD1(G93A) mouse model of amyotrophic lateral sclerosisDeletion of Galectin-3 Enhances Xenobiotic Induced Murine Primary Biliary Cholangitis by Facilitating Apoptosis of BECs and Release of Autoantigens.Lack of galectin-1 or galectin-3 alters B cell deletion and anergy in an autoantibody transgene modelLoss of galectin-3 decreases the number of immune cells in the subventricular zone and restores proliferation in a viral model of multiple sclerosis.Cuprizone demyelination induces a unique inflammatory response in the subventricular zoneGalectin-3 modulates Th17 responses by regulating dendritic cell cytokines.Prognostic value of plasma galectin-3 levels after aneurysmal subarachnoid hemorrhage.Glycobiology of immune responsesGalectins in acute and chronic inflammation.IL-33/ST2 axis in inflammation and immunopathology.Evolving mechanistic insights into galectin functions.Galectin-3 in autoimmunity and autoimmune diseases.Re-wiring regulatory cell networks in immunity by galectin-glycan interactions.Tissue- and cell-specific localization of galectins, β-galactose-binding animal lectins, and their potential functions in health and disease.Effect of sphingosine kinase modulators on interleukin-1β release, sphingosine 1-phosphate receptor 1 expression and experimental autoimmune encephalomyelitis.The Role of Galectin-3: From Oligodendroglial Differentiation and Myelination to Demyelination and Remyelination Processes in a Cuprizone-Induced Demyelination Model.Calcium intervention ameliorates experimental model of multiple sclerosis.Galectin-3 Plays an Important Pro-inflammatory Role in the Induction Phase of Acute Colitis by Promoting Activation of NLRP3 Inflammasome and Production of IL-1β in Macrophages.Galectin-3 deficiency accelerates high-fat diet-induced obesity and amplifies inflammation in adipose tissue and pancreatic isletsMammalian target of rapamycin protein complex 2 regulates differentiation of Th1 and Th2 cell subsets via distinct signaling pathways.Elevated Galectin-3 Levels in the Serum of Patients With Alzheimer's Disease.
P2860
Q27003889-39A53A53-5109-4A02-9BBD-B4501CABFCE7Q27863426-AD1C46C3-30EA-44AA-91B2-1A1409846FD9Q28261890-A108E0CD-FF89-4651-95FC-4043FCC63423Q28272886-F46989F4-B079-44C2-987A-F4FD94F0E532Q28553963-7C25C461-D5CE-44CC-A65F-8BA3EEB34BE7Q33761191-3EDFE7D5-FD28-4CEB-95DA-F1AFAF9AC5F2Q33834605-6637D663-D49B-4670-8BEF-028F24679199Q34052231-46C5B800-604C-454A-A5F4-16C92238D7F5Q34073891-755EE5AE-FD54-4878-B9A4-757DD037633EQ34168523-C20757E3-EBCF-4B1D-999F-CE96EA3EF64AQ34428400-792DEFE6-C3CB-44A9-8F49-46162E357A95Q34537231-60E1A32E-4075-4780-AAFB-7800FCC230DFQ34691040-AA681A97-2C6F-480A-B45F-C89564236778Q35302064-9ACD7F10-ADCB-4306-A73E-B7CAE674423AQ35678838-88C637DB-BBE2-4825-9468-298A2F6B9F66Q35994160-0312B64E-7D3F-4E65-A2BE-54AB105E4289Q36175773-A121D9B2-3394-47D2-856B-8D2B4BD267E7Q36191881-53B76A04-987E-428B-9B94-7C07E5BC51C1Q36196146-4986CAA3-CAE4-40C8-9C5E-1B88D6859668Q36373508-76F2A5BB-077E-4243-8A9B-CFEADD7ECE75Q36708065-F0E91BCD-B25D-477B-A2BD-64FDA3561E98Q36900466-5F1260A6-619C-4E3A-AC9D-6B0C68F95804Q37183047-10BFEDB9-8318-493B-AFD7-711655310B7DQ37195993-5BBCB395-893E-4B17-8378-D8237BACF0CAQ37218244-4F70929B-E873-4065-AEC1-3144050B3F63Q37339791-2EFFF925-90BE-4F76-A23D-6DE0A0BE3758Q37448685-A564C024-B5E1-4978-A039-CF172C1ADB93Q37983646-77657169-1E2A-440B-B157-D0F08186410DQ37990785-D68C6152-4C33-4314-89E3-9D7589A0128DQ38254055-495B3546-0792-46E9-A412-DB39FBB1425CQ38542678-B793DDEC-C175-4DEF-9EAA-87FCD72F18BFQ38583449-EB567FC4-3F8F-4AB3-B1B7-A7D71F1A0371Q38945365-99681C65-D1C2-490B-96C0-F0A723C681A8Q39172652-14AE1FDE-6029-4F0E-B8C4-4289E972A29AQ39313817-DFB0F865-5158-49D3-8960-C0D6FAE56D4BQ40542150-D54AA693-D0DA-4A3F-BFEB-9C45743E5F90Q40826225-D47ABA2E-0F6F-4B37-974F-B609CF4EDB57Q40944709-5C9C1446-E840-4421-BF7F-BC4B091BD6A5Q42099912-36DFAE58-89A6-4F43-95E4-0EA31CC36A0BQ42256539-C9C5A041-4CAA-4C0E-B4A4-CB65FC19C988
P2860
Galectin-3 deficiency reduces the severity of experimental autoimmune encephalomyelitis.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Galectin-3 deficiency reduces the severity of experimental autoimmune encephalomyelitis.
@en
Galectin-3 deficiency reduces the severity of experimental autoimmune encephalomyelitis.
@nl
type
label
Galectin-3 deficiency reduces the severity of experimental autoimmune encephalomyelitis.
@en
Galectin-3 deficiency reduces the severity of experimental autoimmune encephalomyelitis.
@nl
prefLabel
Galectin-3 deficiency reduces the severity of experimental autoimmune encephalomyelitis.
@en
Galectin-3 deficiency reduces the severity of experimental autoimmune encephalomyelitis.
@nl
P2093
P1476
Galectin-3 deficiency reduces the severity of experimental autoimmune encephalomyelitis.
@en
P2093
Allen Shahin
Eric Mensah-Brown
Fu-Tong Liu
Hui-Rong Jiang
Miodrag L Lukic
Sandra Y Fukada
Zakeya Al Rasebi
P304
P356
10.4049/JIMMUNOL.182.2.1167
P407
P577
2009-01-01T00:00:00Z